Glauser, T, Ben-Menachem, E, Bourgeois, B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006; 47:1094–120.CrossRefGoogle ScholarPubMed

Perucca, E, Tomson, T. The pharmacological treatment of epilepsy in adults. Lancet Neurol 2011; 10:446–56.CrossRefGoogle ScholarPubMed

French, J A, Kanner, A M, Bautista, J, et al. Efficacy and tolerability of the new antiepileptic drugs, I: treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004; 45:401–09.Google ScholarPubMed

National Institute for Clinical Excellence. Clinical Guideline 20. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. October 2004. Available at: www.nice.org.uk/nicemedia/live/10954/29532/29532.pdf (accessed January 1, 2011).Google Scholar

Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy in adults. A national clinical guideline. April 2003, updated October 20, 2005. Available at: www.sign.ac.uk/pdf/sign70.pdf (accessed January 1, 2011).Google Scholar

Brodie, M J, Perucca, E, Ryvlin, P, et al. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007; 68:402–08.CrossRefGoogle ScholarPubMed

Glauser, T A, Cnaan, A, Shinnar, S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010; 362(9):790–99.Google Scholar

Marson, A G, Al-Kharusi, A M, Alwaidh, M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369:1000–15.Google ScholarPubMed

Marson, A G, Al-Kharusi, A M, Alwaidh, M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369:1016–26.Google ScholarPubMed

Kale, R, Perucca, E. Revisiting phenobarbital for epilepsy. Br Med J 2004; 329:1199–200.CrossRefGoogle ScholarPubMed

Harden, C L, Meador, K J, Pennell, P B, et al. Practice Parameter update: Management issues for women with epilepsy – focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes. Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and American Epilepsy Society. Epilepsia 2009; 50:1237–46.Google Scholar

Meador, K J, Baker, G A, Browning, N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009; 360:1597–605.CrossRefGoogle ScholarPubMed

Tomson, T, Battino, D, Bonizzoni, E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011; 10(7):609–17.CrossRefGoogle ScholarPubMed